Profile: Crescendo’s Kevin Lee
Kevin Lee founded Crescendo Equity Partners to spot overlooked Korean technology suppliers and reposition them as global leaders of their niches. This required a rare combination of skills
Kevin Lee, founder of Korea’s Crescendo Equity Partners, got his first taste of private equity in 2006, when KKR, Bain Capital, Silver Lake Partners, Apax Partners, and AlpInvest Partners acquired Dutch...
Co-Stone leads $43m round for China biosynthesis player
Co-Stone Capital Management has led a CNY 300m (USD 43m) Series B round for Readline, a Shenzhen-based company that specialises in synthetic biology.
Australia’s Heal Partners closes debut fund on $137m
Australia’s Heal Partners, a health, education, and lifestyle-focused venture capital firm, has closed its first fund on AUD 200m (USD 137m). The target was AUD 100m.
US regulator gets access to Chinese audits
The threat of delisting that has haunted Chinese companies that trade on US exchanges appears to have receded after the US regulators announced they had gained full access to the audits of these companies for the first time.